Richard Jenner

Professor of Molecular Biology.
RNA, chromatin and transcriptional regulation.

[UCL Cancer Institute @uclcancer]

Independent Senior Research Fellow position available! Working between UCL and UCLH, you will apply machine learning to digital pathology data and electronic health records to drive new insights in cancer biology and improve patient care.

To apply: https://t.co/6oZWN5rKDf

[Richard Jenner @RegGenomics]

Does PRC2 interact with RNA or is it an artefact? See our preprint showing how stringent denaturing purifications with spike-in controls support direct interaction between PRC2 and RNA in cells. https://t.co/RwMWdPpROk

[Igor Ulitsky @IgorUlitsky]

Now out in @NatureBiotech ! Do lncRNAs commonly bind 1000s of genomic sites? Maybe they do, but the dozens of studies that report genomic binding maps of lncRNAs are deeply flawed, with probes binding suprious DNA sites rather than RNA-bound ones. https://t.co/01NroM67dK

[UCL Cancer Institute @uclcancer]

Computational analysis is playing an ever increasing role in the detection, management and understanding of cancer.

Equip yourself with the knowledge and skills to lead work in these areas with our new MSc in Computational Cancer, run with @UCLmedphys

https://t.co/DRLOIYY8wy

[Richard Jenner @RegGenomics]

Looking forward to hosting the next meeting of the London RNA Club on RNA Regulation in the Nucleus.

Wednesday 25th March at UCL.

Speakers including @BrockdorffLab, @Vichaico, @RobertVendramin and Folkert van Werven.

https://t.co/qAjjCXY731 to register.

[Quezada Lab @QuezadaLab]

Come join our team!! https://t.co/aA0YanfGEk

[Colorado RNA Club @ColoradoRNAClub]

We’re excited to kick off 2026 with a joint meeting with the London RNA Club, featuring Mary Ann Allen and @stojic_lovorka!

🗓 Wednesday, February 25, 2026
⏰ 10:00 AM MST
📍 Zoom: please RSVP here for link: https://t.co/aQGsTJE3wb

Supported by @RNASociety

[Lovorka Stojic @stojic_lovorka]

To RNA aficionados! We are organising the @GenSocUK meeting “RNA in Physiology and Disease" in Newcastle from 7- 9 Sept. Many opportunities for short talks and an excellent line-up of speakers. More info👇
https://t.co/hge8iqQKY1
Please share🙏

[Chen Davidovich @DavidovichLab]

H3K79me2/3 is sufficient to antagonise PRC1 https://t.co/junFSOvyjO

[Igor Ulitsky @IgorUlitsky]

A preprint‼️that's bound to ruffle some 🪶 "Widespread DNA off-targeting confounds studies of RNA chromatin occupancy" led by our @MicahGoldrich and Louis Delhaye from @pieter_mestdagh. TL;DR we show that many of lncRNA chromatin occupancy maps are flawed🧵https://t.co/eCq6nORxQm

[Richard Jenner @RegGenomics]

@UCLHresearchand & @uclcancer are recruiting an independent Research Fellow and Clinical Training Fellow.

Research areas: Cancer Immunotherapy, Early Diagnosis, Tumour Heterogeneity and Targeted Therapy and Non-chemo Treatments

https://t.co/nkyayW2dhw
https://t.co/k4Qw0WCVsG

[Richard Jenner @RegGenomics]

Interested in applying your molecular biology skills to improve tumour immunotherapy?

@CRUKCOLcentre PhD studentship available in my lab @uclcancer in collaboration with @diunguyen_vn_uk @Bartscancer

For more information and to apply: https://t.co/7de3jrriUc

[Quezada Lab @QuezadaLab]

Are you looking for a Clinical Research Training Fellowship? Do you want join our team working in cancer immunology and immunotherapy? Check this great opportunity from @CRUKCOLcentre
https://t.co/AHeV3QjwSY
 and contact our team to discuss our proposed project

[Richard Jenner @RegGenomics]

@quezada This work reveals mechanisms that regulate CD4+ TCTX function in tumours and highlights the potential therapeutic utility of targeting post-transcriptional regulatory pathways in T cells for the treatment of cancer. 8/8

[Richard Jenner @RegGenomics]

Pleased to share our preprint describing a central role for post-transcriptional processes in the response to cancer immunotherapy. Huge amount of work led by Maria Vila de Mucha and @julia_hlond in collaboration with @QuezadaLab and @MartT_babraham 1/8

https://t.co/o5zDjBEC6X

[Richard Jenner @RegGenomics]

@quezada Constitutive expression of Zfp36l1 in T cells nullified anti-tumour responses while knocking out Zfp36l1 and its paralogue Zfp36 released the block to GzmB protein production and promoted tumour control. 7/8